Selectis Health (GBCS) Depreciation & Amortization (CF) (2010 - 2025)

Selectis Health (GBCS) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $364699.0 in Q3 2025.

• Quarterly Depreciation & Amortization (CF) fell 2.52% year-over-year to $364699.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 30.54% YoY) and the FY2025 annual result came in at $1.5 million, down 6.09% from the prior year.
• Depreciation & Amortization (CF) improved to $364699.0 in Q3 2025 per GBCS's latest filing, from $362742.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $453608.0 in Q3 2022, with the low at $357868.0 in Q3 2023.
• Average Depreciation & Amortization (CF) over 5 years is $413306.3, with a median of $430754.0 recorded in 2023.
• Year-over-year, Depreciation & Amortization (CF) rose 18.21% in 2021 and fell 21.11% in 2023.
• Selectis Health's Depreciation & Amortization (CF) stood at $447070.0 in 2021, then retreated by 0.64% to $444195.0 in 2022, then declined by 3.03% to $430754.0 in 2023, then fell by 15.79% to $362723.0 in 2024, then rose by 0.54% to $364699.0 in 2025.
• Business Quant data shows GBCS's Depreciation & Amortization (CF) at $364699.0 in Q3 2025, $362742.0 in Q2 2025, and $363020.0 in Q1 2025.